Stockreport

LAVA Announces Annual Meeting of Shareholders

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF UTRECHT, The Netherlands and PHILADELPHIA, June 10, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company fo [Read more]